Rosetta Genomics Ltd. Accounts Receivable
Rosetta Genomics Ltd. had Accounts Receivable of $472.00 thousand as of 2017-06-30, per its 6-K filed 2017-10-10.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2017-10-10
- 2017-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $472.00K.
- 2016-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $331.00K; Accounts Receivable, after Allowance for Credit Loss, Current as first filed $2.85M.
- 2016-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $3.37M.
- 2015-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $345.00K; Accounts Receivable, after Allowance for Credit Loss, Current as first filed $3.63M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current | Accounts Receivable, after Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2017-06-30 | $472.00K 6-K · filed 2017-10-10 | |
| 2016-12-31 | $331.00K 6-K · filed 2017-10-10 | $2.85M 20-F · filed 2017-03-30 |
| 2016-06-30 | $3.37M 6-K · filed 2016-09-26 | |
| 2015-12-31 | $345.00K 6-K · filed 2017-10-10 | $3.63M 20-F · filed 2016-03-23 |
| 2015-06-30 | $5.02M 6-K · filed 2015-10-26 | |
| 2014-12-31 | $338.00K 6-K · filed 2016-12-08 | |
| 2014-06-30 | $444.00K 6-K · filed 2014-09-17 | |
| 2013-12-31 | $224.00K 20-F · filed 2015-03-16 | |
| 2013-06-30 | $185.00K 6-K · filed 2013-09-09 | |
| 2012-12-31 | $88.00K 20-F · filed 2014-03-31 | |
| 2012-06-30 | $8.00K 6-K · filed 2012-09-28 | |
| 2011-12-31 | $11.00K 20-F · filed 2013-03-22 | |
| 2010-12-31 | $21.00K 6-K · filed 2012-12-07 |